Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Vilanterol

An ultra-long-acting beta-2 agonist that relaxes the airway muscles for 24 hours. Approved in 2013, it is used in chronic obstructive pulmonary disease (COPD) and asthma. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It was approved in May 2013 not on its own but in a combination inhaler with a corticosteroid, fluticasone furoate; combinations with an antimuscarinic (umeclidinium) and with both followed later.

VilanterolGo to the active ingredient →
VilanterolActive ingredientVilanterolCat. No. P-V040-001CAS 503068-34-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.